The present invention discloses novel substituted aryl alkylamine
compounds of Formula (I) or pharmaceutically acceptable salts thereof
which have selective histamine-H3 receptor antagonist activity as well as
methods for preparing such compounds. In another embodiment, the
invention discloses pharmaceutical compositions comprising such cyclic
amines as well as methods of using them to treat obesity and other
histamine H3 receptor-related diseases ##STR00001##